tiprankstipranks
Rain Oncology (RAIN)
NASDAQ:RAIN
US Market
Holding RAIN?
Track your performance easily

Rain Oncology (RAIN) Technical Analysis

239 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
3Neutral
8Bearish
Technical Analysis Consensus
Buy
6Bullish
3Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Rain Oncology’s (RAIN) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Rain Oncology is a Buy.
Rain Oncology’s (RAIN) 20-Day exponential moving average is 1.21, while Rain Oncology’s (RAIN) share price is $1.21, making it a Buy.
Rain Oncology’s (RAIN) 50-Day exponential moving average is 1.18, while Rain Oncology’s (RAIN) share price is $1.21, making it a Buy.

Rain Oncology (RAIN) Pivot Points

Dec 21, 2024, 02:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.13
1.17
1.19
1.23
1.25
1.29
1.31
Fibonacci
1.17
1.19
1.21
1.23
1.25
1.27
1.29
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Rain Oncology (RAIN) Moving Averages

Dec 21, 2024, 02:29 PM
Period
Simple
Exponential
MA5
1.21Buy
1.21Sell
MA10
1.22Sell
1.21Sell
MA20
1.21Sell
1.21Buy
MA50
1.17Buy
1.18Buy
MA100
1.07Buy
1.42Sell
MA200
2.02Sell
2.82Sell
Rain Oncology’s (RAIN) 10-Day exponential moving average is 1.21, while Rain Oncology’s (RAIN) share price is $1.21, making it a Sell.
Rain Oncology’s (RAIN) 100-Day exponential moving average is 1.42, while Rain Oncology’s (RAIN) share price is $1.21, making it a Sell.
Rain Oncology’s (RAIN) stock price is $1.21 and Rain Oncology’s (RAIN) 50-day simple moving average is 1.17, creating a Buy signal.
Rain Oncology’s (RAIN) stock price is $1.21 and Rain Oncology’s (RAIN) 100-day simple moving average is 1.07, creating a Buy signal.
Rain Oncology’s (RAIN) stock price is $1.21 and Rain Oncology’s (RAIN) 200-day simple moving average is 2.02, creating a Sell signal.

Rain Oncology (RAIN) Technical Indicators

Dec 21, 2024, 02:29 PM
Name
Value
Implied Action
RSI (14)
53.89
Neutral
STOCH (9,6)
14.29
Buy
STOCHRSI (14)
17.86
Buy
MACD (12,26)
0.01
Buy
ADX (14)
44.96
Neutral
Williams %R
-85.71
Buy
CCI (14)
77.03
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
17.21
Sell
ROC
0.83
Buy
Rain Oncology’s (RAIN) Relative Strength Index (RSI) is 53.89, creating a Neutral signal.
Rain Oncology’s (RAIN) Trend Strength Indicator (ADX) is 44.96, creating a Neutral signal.
Rain Oncology’s (RAIN) Commodity Channel Index (CCI) is 77.03, creating a Neutral signal.
Rain Oncology’s (RAIN) Price Rate of Change (ROC) is 0.83, creating a Buy signal.

FAQ

Is RAIN a Buy, Hold, or Sell?
Based on RAIN’s technical indicators, RAIN is a Buy.
    What is RAIN’s RSI (14)?
    RAIN’s RSI (14) is 53.89, which suggests RAIN is a Neutral.
      What is RAIN’s MACD?
      RAIN’s MACD is 0.01, which suggests RAIN is a Buy.
        What is RAIN’s 5-day moving average?
        RAIN’s 5-day moving average is 1.21, which suggests RAIN is a Buy.
          What is RAIN’s 20-day moving average?
          RAIN 20-day moving average is 1.21, which suggests RAIN is a Sell.
            What is RAIN’s 50-day moving average?
            RAIN’s 50-day moving average is 1.17, which suggests RAIN is a Buy.
              What is RAIN’s 200-day moving average?
              RAIN’s 200-day moving average is 2.02, which suggests RAIN is a Sell.
                What is RAIN’s Williams % R (14)?
                RAIN’s Williams % R (14) is -85.71, which suggests RAIN is a Buy.
                  What is RAIN’s CCI (14)?
                  RAIN’s CCI (14) is 77.03, which suggests RAIN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis